The aim is to ensure that the patients are functionally adequately and painlessly mobilized with the proximal femoral tumor resection prosthesis used, to increase the survival of patients who underwent wide resection, and to determine the complications of the treatment applied and the clinical performance of the Moment Tumor Hip Replacement Products used.
This study is a 6-center, prospective local medical device clinical trial. Trial period is 6 months. Patient recruitment will continue until the target sample number determined by the power analysis is reached. Since the application is surgical, it is within the scope of a one-time application. The patients will be followed for 6 months from the day of surgery. The study was designed as a prospective cohort study planned to be cross-sectional. The aim of this study is to ensure that the patients are functionally adequately and painlessly mobilized with the proximal femoral tumor resection prosthesis used, to increase the survival of patients who underwent wide resection, and to determine the complications of the treatment applied and the clinical performance of the Moment Tumor Hip Replacement Products used and to contribute to the medical literature on proximal femoral resection prosthesis as a result of the study.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Enrollment
42
In the case of irreversible bone loss due to bone tumors, large and multi-part fractures, and pseudarthrosis in the proximal region of the femur bone, the defective bone area is removed and implants made of artificial materials are placed in order to replace the integrity of the bone. In addition, implant applications are made to the proximal femur region for the purpose of revision arthroplasty, which is typically replaced by total hip prosthesis depending on the wear condition. In this way, the bone integrity will be preserved, long-term stabilization will be provided to the patient and existing pain will be eliminated. Moment Tumor Hip Replacement Systems consist of proximal main body, extension pieces and intramedullary stems. Components are available in a variety of sizes to meet anatomical requirements and surgeon needs.
Gazi University Faculty of Medicine
Ankara, Turkey (Türkiye)
Hacettepe University Faculty of Medicine
Ankara, Turkey (Türkiye)
Pamukkale University Faculty of Medicine
Denizli, Turkey (Türkiye)
Eskişehir Osmangazi University Health Practice and Research Hospital
Eskişehir, Turkey (Türkiye)
Rate of Adverse Events
Reliability of the procedure (adverse events occurring)
Time frame: 6 Months
Number of participants with treatment-related adverse events as assessed by CTCAE v4.0
Toleratibily of the patients for the procedure.
Time frame: 6 Months
Hip pain and function for 6 months after the procedure according to the MSTS scoring
Hip pain and function for 6 months after the procedure according to the MSTS scoring
Time frame: 6 Months
Change in Quality of life
Determination of the change in quality of life from baseline to 6 month after the procedure
Time frame: 6 Months
Improvement in Functional Parameters
Percent change in in functional parameters compared to baseline during the follow-up period.
Time frame: 6 Months
Complications
Complications will be evaluated in patients with complications according to the Henderson classification.
Time frame: 6 Months
Procedure's Safety
Number of adverse event: observed adverse events (AE) with the help of radiographic evaluations and Examinations performed
Time frame: 6 Months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Istanbul Göztepe Prof.Dr. Suleyman Yalcin City Hospital
Istanbul, Turkey (Türkiye)
Necmettin Erbakan University Meram Faculty of Medicine
Konya, Turkey (Türkiye)
Cumhuriyet University School of Medicine
Sivas, Turkey (Türkiye)